[HTML] cell.com

[HTML][HTML] Tartrate-resistant acid phosphatase 5/ACP5 interacts with p53 to control the expression of SMAD3 in lung adenocarcinoma

Y Hu, J Yu, Q Wang, L Zhang, X Chen, Y Cao… - Molecular Therapy …, 2020 - cell.com
Tartrate-resistant acid phosphatase 5 (TRAP/ACP5) has been shown to involve the
development and prognosis of multiple tumors in previous studies; however, the mechanism …
被引用次数：27 相关文章
[HTML] nih.gov

[HTML][HTML] Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma

Y Hu, J Yu, Q Wang, L Zhang, X Chen… - Molecular Therapy …, 2020 - ncbi.nlm.nih.gov
Tartrate-resistant acid phosphatase 5 (TRAP/ACP5) has been shown to involve the
development and prognosis of multiple tumors in previous studies; however, the mechanism …

Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma.

Y Hu, J Yu, Q Wang, L Zhang, X Chen… - Molecular Therapy …, 2020 - europepmc.org
Tartrate-resistant acid phosphatase 5 (TRAP/ACP5) has been shown to involve the
development and prognosis of multiple tumors in previous studies; however, the mechanism …

Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma

Y Hu, J Yu, Q Wang, L Zhang… - Molecular therapy …, 2020 - pubmed.ncbi.nlm.nih.gov
Tartrate-resistant acid phosphatase 5 (TRAP/ACP5) has been shown to involve the
development and prognosis of multiple tumors in previous studies; however, the mechanism …
[HTML] sciencedirect.com

[HTML][HTML] Tartrate-Resistant Acid Phosphatase 5/ACP5 Interacts with p53 to Control the Expression of SMAD3 in Lung Adenocarcinoma

Y Hu, J Yu, Q Wang, L Zhang, X Chen, Y Cao… - Molecular Therapy …, 2020 - Elsevier
Tartrate-resistant acid phosphatase 5 (TRAP/ACP5) has been shown to involve the
development and prognosis of multiple tumors in previous studies; however, the mechanism …